GK News 2 - шаблон joomla Видео

Banner1

Log in
Powered by Spearhead Software Labs Joomla Facebook Like Button

PHYLLODES TUMOR OF THE BREAST : A CLINICOPATHOLOGICAL ANALYSIS FROM A SINGLE INSTITUTION

Naoual Benhmidou1, Fadoua Rais1, Fadila Kouhen2, Abdelhak Maghous1, Hasna Loughlimi1, Khadija Bellahammou3, Hanan Elkacemi1, Tayeb Kebdani1, Sanaa Elmajjaoui1, Noureddine Benjaafar1

1) Department of Radiotherapy, National Institute of Oncology, Mohammed V University in Rabat, Morocco.

2) Department of Radiotherapy, International University Hospital Sheikh Khalifa, Casablanca, Morocco

3) Department of Medical Oncology, National Institute of Oncology, Rabat, Morocco.

Disclosure: The author has declared no conflicts of interest.

Received: 11.07.16 Accepted: 01.08.16

Citation: 10.5455/ijsm.phyllodes-tumor-breast

Fulltext PDF Download

Cite/Export: EndNote/RefWorks

altmetric journalmedica

Abstract:

The aim of our study is to examine the clinical and pathological features of patients with breast phyllodes tumors and to determine features that are correlated to outcome. Forty four phyllodes tumors were assessed. There were 11 benign, 11 borderline and 22 malignant tumors. 10 of 44 patients (22.72 %) relapsed at any site. Seven patients (15.9 %) had a local recurrence and 3 patients experienced local and metastatic relapse. The 5-year and 10-year survival rates are 97% and 95 % respectively. The 5 years and 10 years DFS are 81% and 77% respectively. Grade, histological size, margin involvement impacted disease free survival. Adjuvant radiation therapy improved local control in high grade tumors although it did not reach significance.

Keywords: Phyllodes tumors, recurrence, prognostic factors


How to Cite this Article

Benhmidou, N. et al., 2017. PHYLLODES TUMOR OF THE BREAST : A CLINICOPATHOLOGICAL ANALYSIS FROM A SINGLE INSTITUTION. International Journal of Surgery and Medicine, 3(2), p.1. Available at: http://dx.doi.org/10.5455/ijsm.phyllodes-tumor-breast.

Cited by

google scholar

Leave a comment

Make sure you enter the (*) required information where indicated. HTML code is not allowed.